502 results on '"Chamaillard, Mathias"'
Search Results
52. Defining dysbiosis threatens Kochʼs postulates and current dogma on the role of Paneth cells in Crohnʼs disease
53. A Protective Role of NOD2 on Oxazolone-induced Intestinal Inflammation Through IL-1β-mediated Signalling Pathway.
54. Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease
55. M‐CSF‐mediated macrophage development is dominantly inhibited by NOD2 signaling for replenishment of immunogenic dendritic cells
56. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts
57. CANCER IMMUNOTHERAPY: Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
58. Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation
59. Time for epithelial sensing of vitamin D to step into the limelight
60. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
61. NOD1 sensing of house dust mite–derived microbiota promotes allergic experimental asthma
62. Oral Supplementation With Selected Lactobacillus Acidophilus Triggers Antimicrobial Response, Activation of Innate Lymphoid Cells Type 3 And Improves Colitis
63. NOD2: a potential target for regulating liver injury
64. Longest Form of CCTG Microsatellite Repeat in the Promoter of the CD2BP1/PSTPIP1 Gene Is Associated with Aseptic Abscesses and with Crohn Disease in French Patients
65. CCL17 Production by Dendritic Cells Is Required for NOD1-mediated Exacerbation of Allergic Asthma
66. Pseudomonas aeruginosa Type-3 Secretion System Dampens Host Defense by Exploiting the NLRC4-coupled Inflammasome
67. (Mu)-Opioid receptor activation prevents acute hepatic inflammation and cell death
68. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?
69. The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review
70. Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation
71. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition
72. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease
73. IL17 and/or IL22 as Potential Target(s) for Crohn’s Disease
74. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
75. Looking beyond histological healing in ulcerative colitis: towards the establishment of a molecular signature for quiescent but progressive disease
76. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation
77. Advances and Perspectives in the Genetics of Inflammatory Bowel Diseases
78. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
79. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
80. Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies
81. Candida albicans Colonization and ASCA in Familial Crohnʼs Disease
82. Detection of Antisynthetic Mannoside Antibodies (AΣMA) Reveals Heterogeneity in the ASCA Response of Crohnʼs Disease Patients and Contributes to Differential Diagnosis, Stratification, and Prediction
83. μ-Opioid receptor activation prevents acute hepatic inflammation and cell death
84. Vascular and Cellular Stress in Inflammatory Bowel Disease: Revisiting the Role of Homocysteine
85. Battling enteroinvasive bacteria: Nod1 comes to the rescue
86. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
87. Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis
88. The Ubiquitin Code of NODs Signaling Pathways in Health and Disease
89. A dietary flavone confers communicable protection against colitis through NLRP6 signaling independently of inflammasome activation
90. Intestinal microbiota: what to expect physiologically and therapeutically?
91. The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection
92. The regenerating family member 3 β instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of microbiota community structure
93. Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model
94. Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: “Integrin a6 variants and colorectal cancer” by Beaulieu JF
95. Susceptibility of Card9-/- mice to intestinal pathogen is partly microbiota dependant
96. Type I interferons drive inflammasome-independent emergency monocytopoiesis during endotoxemia
97. Keeping the (S)toolbox Alive Outside of the Body for Drugs Discovery
98. Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence
99. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice
100. Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.